Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease
- PMID: 31293503
- PMCID: PMC6603092
- DOI: 10.3389/fneur.2019.00662
Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease
Abstract
Objective: To estimate the association between p. R4810K variant and clinical outcomes of patients with moyamoya disease (MMD). Methods: The p.R4810K genetic variant was genotyped among 498 Chinese patients with MMD conducted from June 1, 2012, to June 31, 2017. Data was obtained by retrospective chart review, follow-up information and outcome were obtained through clinical visits and telephone. Results: Among 498 patients, 361 (72.5%) were wild-type patients (G/G), 133 (26.7%) heterozygous patients (G/A), and 4 (0.8%) homozygotes (A/A). Compared with GG group, the patients in the G/A+A/A group were younger at diagnosis and had more familial cases, more transient ischemic attack cases, more posterior cerebral artery involved hemispheres, less unilateral lesions. After the median 53 months follow-up, strokes occurred in 9 patients in the G/A+A/A group and in 52 in the G/G group. Multivariate Cox regression analysis showed that the history of hypertension (HR, 2.294; 95% CI, 1.251-4.206; p = 0.007), the presence of TIA (HR, 0.319; 95% CI, 0.120-0.846; p = 0.022), and the Suzuki stage (HR, 1.510; 95% CI, 1.129-2.018; p = 0.005) were associated with recurrent stroke. The p.R4810K (HR, 0.601; 95% CI, 0.292-1.239; p = 0.168) was not associated with recurrent stroke. Multivariate logistic regression analysis showed that recurrent stroke (OR, 5.997; 95% CI, 2.583-13.924; p = 0.000) was the only factor associated with unfavorable neurological status. And the p.R4810K (OR, 0.885; 95% CI, 0.482-1.627; p = 0.695) was not associated with neurological status. Conclusions: Compared to the patients in G/G group, patients in G/A+A/A group exhibited different clinical features, and had a lower rate of recurrent stroke and better clinical outcome after early medical and surgical interventions. Multivariate COX and logistic regression analysis showed that p.R4810Kvariant was not related to either recurrent stroke or neurological status. The p.R4810Kvariant may not be associated with long-term clinical outcome in Chinese patients with MMD.
Keywords: clinical features; clinical outcome; moyamoya disease; p.R4810K variant; stroke.
Similar articles
-
The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease.Hum Mutat. 2024 Apr 24;2024:1844190. doi: 10.1155/2024/1844190. eCollection 2024. Hum Mutat. 2024. PMID: 40225941 Free PMC article.
-
Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.J Stroke Cerebrovasc Dis. 2021 Jul;30(7):105847. doi: 10.1016/j.jstrokecerebrovasdis.2021.105847. Epub 2021 May 13. J Stroke Cerebrovasc Dis. 2021. PMID: 33992965
-
Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.World Neurosurg. 2016 Jun;90:530-538.e3. doi: 10.1016/j.wneu.2015.12.093. Epub 2016 Jan 12. World Neurosurg. 2016. PMID: 26806063
-
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.J Neurosurg. 2016 May;124(5):1221-7. doi: 10.3171/2015.4.JNS142900. Epub 2015 Oct 2. J Neurosurg. 2016. PMID: 26430847
-
A new horizon of moyamoya disease and associated health risks explored through RNF213.Environ Health Prev Med. 2016 Mar;21(2):55-70. doi: 10.1007/s12199-015-0498-7. Epub 2015 Dec 10. Environ Health Prev Med. 2016. PMID: 26662949 Free PMC article. Review.
Cited by
-
Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant.BMC Neurol. 2020 Aug 19;20(1):308. doi: 10.1186/s12883-020-01884-0. BMC Neurol. 2020. PMID: 32814565 Free PMC article.
-
RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population.Ann Transl Med. 2020 Jul;8(14):851. doi: 10.21037/atm-20-1040. Ann Transl Med. 2020. PMID: 32793695 Free PMC article.
-
RNF213 p.Arg4810Lys Wild Type is Associated with De Novo Hemorrhage in Asymptomatic Hemispheres with Moyamoya Disease.Transl Stroke Res. 2024 Aug;15(4):729-738. doi: 10.1007/s12975-023-01159-z. Epub 2023 Jun 3. Transl Stroke Res. 2024. PMID: 37269436 Free PMC article.
-
Emerging Concept of Intracranial Arterial Diseases: The Role of High Resolution Vessel Wall MRI.J Stroke. 2024 Jan;26(1):26-40. doi: 10.5853/jos.2023.02481. Epub 2024 Jan 30. J Stroke. 2024. PMID: 38326705 Free PMC article. Review.
-
Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease.Front Neurol. 2022 Jul 26;13:891622. doi: 10.3389/fneur.2022.891622. eCollection 2022. Front Neurol. 2022. PMID: 35959391 Free PMC article.
References
-
- Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. (1969) 20:288–99. - PubMed
LinkOut - more resources
Full Text Sources